Global Schizophrenia Therapeutics Market 2014-2018 - Industry Trends, Size, Share, Growth & Development

Submitted by: Submitted by

Views: 96

Words: 1202

Pages: 5

Category: Business and Industry

Date Submitted: 11/21/2014 10:40 AM

Report This Essay

Global Schizophrenia Therapeutics Market 2014-2018

About Schizophrenia

Schizophrenia is a chronic brain disorder that severely affects the quality of life of a patient by disturbing the normal functioning of the brain. Psychotic symptoms and a diminished range of expression of emotions are the characteristics of schizophrenia.

The exact etiology of schizophrenia is still not known. In men, it appears in the late teens or early 20s, and in women in the late 20s or early 30s. However, most of the symptoms of this disorder can be managed with medication and psychological help.

Browse Complete Report with TOC: http://www.marketresearchstore.com/report/global-schizophrenia-therapeutics-market-2014-2018-1565

TechNavio's analysts forecast the Global Schizophrenia Therapeutics market to grow at a CAGR of 2.82 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Schizophrenia Therapeutics market for the period 2014-2018. To calculate the market size, the report considers revenue generated from sales of various drugs used in the treatment of schizophrenia that are available in the market. The Global Schizophrenia Therapeutics market can be segmented into two: First-generation Antipsychotics and Second-generation Antipsychotics.

TechNavio's report, the Global Schizophrenia Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Schizophrenia Therapeutics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Buy this Report: http://www.marketresearchstore.com/checkout/reportId/1565/reportType/0

Key Regions

• Americas

• APAC

• EMEA

Key Vendors

• AstraZeneca

• Bristol-Myers Squibb

• Eli Lily

• F....